The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes

January 2, 2024 updated by: Bettina Ewers, Steno Diabetes Center Copenhagen

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study): A Randomized, Parallel, Open-label, Intervention Study Comparing Different Approaches to Dietary Self-management in Patients With Type 1 Diabetes

The study is designed to evaluate two different dietitian-led self-management approaches in carbohydrate counting compared to routine dietary care (control) on glycaemic control in adult patients with type 1 diabetes:

  1. The basic carbohydrate counting concept aims at improving carbohydrate counting accuracy and day-to-day consistency of carbohydrate intake (the BCC intervention)
  2. The advanced carbohydrate counting concept aims at improving prandial insulin dose accuracy using an automated bolus calculator (the ABC-ACC intervention)

The main hypothesis is that structured training and education in either the BCC concept or the ABC-ACC concept will reduce HbA1c or the average glucose variability more than routine dietary education.

Study Overview

Detailed Description

The current study is a randomized controlled trial with a parallel-group design. A total of 231 patients will be enrolled in the trial. Participants will be randomized to one of three arms: 1) Basic carbohydrate counting (BCC), 2) Advanced carbohydrate counting with an automated bolus calculator (ABC-ACC), or 3) Standard dietary care.

The primary objective is to evaluate the six months effects of education in the BCC concept and the ABC-ACC concept compared to standard dietary care on glycaemic control as assessed by HbA1c or MAGE (mean amplitude of glycaemic excursions).

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gentofte, Denmark, DK-2820
        • Steno Diabetes Center Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Type 1 diabetes
  • Diabetes duration; >12 months
  • HbA1c of 53-97 mmol/mol
  • Multiple daily insulin injection therapy
  • Provided voluntary written informed consent

Exclusion Criteria:

  • Practicing carbohydrate counting, as judged by the investigator
  • Participated in a BCC group program within the last two years
  • Use of insulin pump, or plans of having an insulin pump within the study period
  • Fixed dose of rapid acting insulin therapy for meals
  • Split-mixed insulin therapy
  • Use of open CGM
  • Use of Freestyle Libre
  • Use of an automated bolus calculator
  • Gastroparesis
  • Pregnancy or breastfeeding, or plans of pregnancy within the study period
  • Low daily intake of carbohydrates (defined as below 25 E% or 100 g/day), as judged by the investigator
  • Uncontrolled medical issues, as judged by the investigator or a medical expert
  • Concomitant participation in other clinical studies
  • Unable to understand the informed consent and the study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BCC intervention
The BCC program consists of three group sessions and is delivered by two trained dietitians. In addition to the BCC program, the participants receive regular medical care in the diabetes clinic
Structured training and education i basic carbohydrate counting principles
Other Names:
  • Basic carbohydrate counting
Experimental: ABC-ACC intervention
The ABC-ACC program consists of one group session and two individual follow-up sessions and is delivered by trained dietitians with supervision by a medical doctor. In addition to the ABC-ACC program, the participants receive regular medical care in the diabetes clinic
Structured training and education i advanced carbohydrate counting principles including the use of a automated bolus calculator carbohydrate
Other Names:
  • Advanced carbohydrate counting with a bolus calculator
Active Comparator: Standard dietary education
The routine outpatient dietary care consists of three individual consultations delivered by a trained dietitian. The individual guidance is based on the overall treatment goal(s), the defined personal dietary goals for behavioral change which will be in accordance with the patient's needs and preferences. In addition to the dietary counselling, the participants receive regular medical care in the diabetes clinic
Personalized individual dietary counselling based on overall meal planning, dietary guidelines and the patient's need and preferences
Other Names:
  • Routine dietary care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HbA1c
Time Frame: Baseline, 6 months
mmol/mol
Baseline, 6 months
Change in mean amplitude of glycaemic excursions (MAGE)
Time Frame: Baseline, 6 months
mmol/l
Baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HbA1c
Time Frame: 12 months
mmol/mol
12 months
Change in body weight
Time Frame: Baseline, 6 months, 12 months
kg
Baseline, 6 months, 12 months
Change in low-density lipoprotein cholesterol (LDL-C)
Time Frame: Baseline, 6 months, 12 months
mmol/l
Baseline, 6 months, 12 months
Change in high-density cholesterol (HDL-C)
Time Frame: Baseline, 6 months, 12 months
mmol/l
Baseline, 6 months, 12 months
Change in total cholesterol (TC)
Time Frame: Baseline, 6 months, 12 months
mmol/l
Baseline, 6 months, 12 months
Change in free fatty acids (FFA)
Time Frame: Baseline, 6 months, 12 months
mmol/l
Baseline, 6 months, 12 months
Change in triglycerides (TG)
Time Frame: Baseline, 6 months, 12 months
mmol/l
Baseline, 6 months, 12 months
Change in diastolic blood pressure
Time Frame: Baseline, 6 months, 12 months
mm Hg
Baseline, 6 months, 12 months
Change in systolic blood pressure
Time Frame: Baseline, 6 months, 12 months
mm Hg
Baseline, 6 months, 12 months
Change in waist circumference
Time Frame: Baseline, 6 months, 12 months
cm
Baseline, 6 months, 12 months
Change in hip circumference
Time Frame: Baseline, 6 months, 12 months
cm
Baseline, 6 months, 12 months
Change in total fat free mass
Time Frame: Baseline, 6 months
gram
Baseline, 6 months
Change in total fat mass
Time Frame: Baseline, 6 months
gram
Baseline, 6 months
Change in standard deviation of mean plasma glucose
Time Frame: Baseline, 6 months
mmol/l
Baseline, 6 months
Change in total energy intake
Time Frame: Baseline, 6 months
kJ/day
Baseline, 6 months
Change in dietary intake of carbohydrates
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in dietary intake of total fat
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in dietary intake of saturated fatty acids (SFA)
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in dietary intake of monounsaturated fatty acids (MUFA)
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in dietary intake of polyunsaturated fatty acids (PUFA)
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in dietary intake of protein
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months
Change in intake of dietary fibre
Time Frame: Baseline, 6 months
gram/day or g/MJ
Baseline, 6 months
Change in time in range (3.9-10.0 mmol/l)
Time Frame: Baseline, 6 months
Percent (%)
Baseline, 6 months
Changes in % time spent in hypoglycaemia (<3.9 mmol/l)
Time Frame: Baseline, 6 months
Percent (%)
Baseline, 6 months
Change % time spent in hyperglycaemia (e.g. >11.1 mmol/l)
Time Frame: Baseline, 6 months
Percent (%)
Baseline, 6 months
Change in mathematical literacy
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in carbohydrate estimation accuracy
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in diet-related quality of life
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in perceived competences in diabetes
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in degree of autonomy-supportive dietitian
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in dietary intake of added sugar
Time Frame: Baseline, 6 months
gram/day or percent of total energy (E%)
Baseline, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity level
Time Frame: Baseline, 6 months, 12 months
Total score or percent (%)
Baseline, 6 months, 12 months
Change in urinary biomarkers of carbohydrate intake
Time Frame: Baseline, 6 months
Percent (%)
Baseline, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Bettina Ewers, MSc, Steno Diabetes Center Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2018

Primary Completion (Actual)

August 17, 2022

Study Completion (Actual)

August 17, 2022

Study Registration Dates

First Submitted

July 19, 2018

First Submitted That Met QC Criteria

August 7, 2018

First Posted (Actual)

August 9, 2018

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 2, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glucose Metabolism Disorders

Clinical Trials on BCC intervention

3
Subscribe